Nemaura Medical (NMRD)
(Delayed Data from OTC)
$0.03 USD
-0.01 (-16.96%)
Updated Sep 13, 2024 12:07 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Nemaura Medical, Inc. [NMRD]
Reports for Purchase
Showing records 1 - 9 ( 9 total )
Company: Nemaura Medical, Inc.
Industry: Medical - Instruments
Company: Nemaura Medical, Inc.
Industry: Medical - Instruments
F2Q24 Financial Results; Update Rating to Under Review
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Nemaura Medical, Inc.
Industry: Medical - Instruments
sugarBEAT Approved in Saudi Arabia; Reiterate Buy; Lowering PT to $2.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Nemaura Medical, Inc.
Industry: Medical - Instruments
F3Q23 Financial Results Reported; Reiterate Buy; Lowering PT to $7
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Nemaura Medical, Inc.
Industry: Medical - Instruments
UK Study Shows Weight Loss in Personalized Wellbeing Program; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Nemaura Medical, Inc.
Industry: Medical - Instruments
Company: Nemaura Medical, Inc.
Industry: Medical - Instruments
F1Q23 Financial Results Reported; Reiterate Buy; Lowering PT to $8
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Nemaura Medical, Inc.
Industry: Medical - Instruments
FY2022 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Nemaura Medical, Inc.
Industry: Medical - Instruments
Monitoring Glucose Continuously Without Needle; Initiating at Buy and $12 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
|